Guild Learning and Development is partnering with Sanofi in the development of an online course, Vitamin D supplementation in bone health
Pharmacists who complete this course will be able to describe the process of bone metabolism, including the role of vitamin D in bone metabolism.
This course will also assist pharmacists in identifying patients who may benefit from 7000IU once-a-week vitamin D supplementation, including important counselling points and advice for patients.
Osteoporosis is a chronic, and often asymptomatic condition, with about half of all patients not realising they have the disease until they suffer from a low-impact fracture.
Patients may also not perceive any direct benefit from treatment1,2 and as a result compliance with osteoporosis medication can be suboptimal.
As vitamin D deficiency is a significant public health issue in Australia, pharmacists play an important role in assessing persistence and compliance with vitamin D therapy in all at-risk individuals, the Guild says.
This activity has been accredited for 0.75 hours of Group 1 CPD (or 0.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 0.75 hours of Group 2 CPD (or 1.5 CPD credits) upon successful completion of relevant assessment activities.
Contact the Guild Learning and Development on 03 9810 9930 or email email@example.com for more information.
Guild Learning and Development has thanked Sanofi for their financial support in the development of this course.
1 Reid DM. Handbook of osteoporosis. London: Springer Healthcare Ltd; 2011.
2 Reginster JY, Rabenda V, Neuprez A. Adherence, patient preference and dosing frequency: Understanding the relationship. Bone. 2006;38(4, Supplement 1):S2-S6. doi: http://dx.doi.org/10.1016/j.bone.2006.01.150